FDAnews Drug Daily Bulletin

Parkinson’s Drug Awaits OK While ADHD Lifts Impax Now

Aug. 17, 2012
A A
While its long-awaited novel drug to treat Parkinson’s disease inches closer to the finish line, Impax Laboratories has found other ways to keep its growth engine humming.
Investors Today